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The bovine spongiform encephalopathy (BSE) agent 
has been transmitted to humans, leading to variant 
Creutzfeldt-Jakob disease. Sheep and goats can be experi-
mentally infected by BSE and have been potentially exposed 
to natural BSE; however, whether BSE can be transmitted to 
small ruminants is not known. Based on the particular bio-
chemical properties of the abnormal prion protein (PrPsc) as-
sociated with BSE, and particularly the increased degrada-
tion induced by proteinase K in the N terminal part of PrPsc, 
we have developed a rapid ELISA designed to distinguish 
BSE from other scrapie strains. This assay clearly discrimi-
nates experimental ovine BSE from other scrapie strains and 
was used to screen 260 transmissible spongiform encephal-
opathy (TSE)–infected small ruminant samples identiﬁ  ed by 
the French active surveillance network (2002/2003). In this 
context, this test has helped to identify the ﬁ  rst case of natural 
BSE in a goat and can be used to classify TSE isolates based 
on the proteinase K sensitivity of PrPsc.
T
ransmissible spongiform encephalopathies (TSEs) 
are neurodegenerative diseases affecting humans and 
animals; examples are scrapie in sheep and goats, bovine 
spongiform encephalopathy (BSE) in cattle, and chronic 
wasting disease in cervids. Strong evidence indicates that 
the BSE agent has been transmitted to humans through 
the food chain, leading to the emergence of variant 
Creutzfeldt-Jakob disease (vCJD). Recently, the ﬁ  rst case 
of natural BSE was identiﬁ  ed in a French goat (1), and 
a second probable one was reported in the United King-
dom (2). It seems, however, that these were isolated cases 
and that the BSE level in small ruminant ﬂ  ocks is prob-
ably low. However, BSE can be transmitted experimen-
tally to sheep and goats by the oral route (3–5), whereas 
small ruminants have very likely been exposed to the BSE 
agent through contaminated meat and bone meal (MBM). 
Given the widespread tissue distribution of the BSE agent 
in sheep and goats, horizontal and vertical transmission 
within sheep and goat populations is possible, which 
could lead to human exposure to the agent through the 
food chain, even after the MBM feed ban.
TSEs are characterized by the accumulation in the brain 
of an abnormal form of the prion protein (PrPsc), which is 
derived from the normal one (PrPc) and manifests as un-
usual biochemical properties including insolubility in the 
presence of detergents and partial resistance to the action of 
proteases like proteinase K (PK). The conventional method 
of identifying a TSE strain is the experimental transmission 
of the disease in several mouse lines (6,7) including trans-
genic mouse lines that over express PrP, thereby increasing 
the efﬁ  ciency and speed of transmission (8–10). However, 
these methods cannot be used as screening methods.
Sophisticated histopathologic and immunohistochemi-
cal methods have also been used to identify TSE strains 
(5,11–15). These methods appear efﬁ  cient in differentiat-
ing BSE from other scrapie strains, but they are time-con-
suming and not suitable for large-scale typing.
Several studies have shown that the resistance of PrP-
sc to PK treatment varies depending on the strain (16–18). 
PrPsc associated with BSE in cattle or sheep is more sen-
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sitive to PK degradation at its amino-terminus than PrPsc 
from scrapie. Recently “atypical” forms of scrapie sensitive 
to PK, such as the Nor98 strain, have been described (19). 
Since 2002, large-scale epidemiologic studies have led to 
the identiﬁ  cation of hundreds of atypical cases in several 
European countries (20); these cases included an unusual 
occurrence in sheep with genotypes previously associated 
with high resistance to scrapie (including the ARR/ARR 
genotype) (21). Converging data show that most atypical 
cases share identical biochemical and biologic features 
with Nor-98 (22).
Glycoform ratios and the molecular migration pat-
tern of PK-treated PrPsc, as obtained in Western blot tech-
niques, enable characterization of scrapie strains and BSE. 
(These topics have been reviewed by Groschup et al. [23]) 
This method identiﬁ  ed similarities between BSE in cattle 
and experimental BSE in sheep (24,25) and similarities 
between vCJD and BSE in cattle (26,27). However, these 
typing immunoblotting techniques are not easily applied to 
test huge numbers of ﬁ  eld samples. To increase speciﬁ  city, 
a differential immunoblotting technique involving 2 spe-
ciﬁ  c antibodies, directed against the amino- and carboxy-
termini of PrP, has been developed (10,28). Comparison of 
the signals obtained for both antibodies provides an easy 
and fast identiﬁ  cation of the BSE strain because binding 
of the anti-N terminal antibody is almost completely sup-
pressed. This approach has been used to characterize un-
usual BSE cases in cattle (29) and naturally infected scrapie 
sheep (14,30).
We describe an ELISA designed to distinguish BSE 
and scrapie strains, on the basis of their differential resis-
tance to PK. The design of this method is similar to that 
of a rapid test widely used in Europe (TeSeE, Bio-Rad, 
Hercules, CA, USA) and allows rapid screening of a large 
number of sheep samples previously shown to contain PK-
resistant prion protein (PrPres) by a conventional test.
Experimental Procedures
Materials
Chemicals were obtained from Sigma (St. Louis, 
MO, USA) except (aminoethyl)benzenesulfonyl ﬂ  uoride) 
(AEBSF) from ICN Pharmaceuticals, Inc. (Costa Mes, CA, 
USA). All other reagents for puriﬁ  cation and detection of 




Experimental samples for scrapie controls 99–1316 
and 99–1487 were from the Veterinary School of Toulouse 
(France) and for PG1259 from the Veterinary Laboratories 
Agency (VLA, Weybridge UK). Experimental ovine BSE-
infected samples (SB1 and SB3 [31]) were from Agence 
Française de Sécurité Sanitaire des Aliments (AFSSA), 
the French national reference laboratory in Lyon. Some 
of the ﬁ  rst-passage experimental ovine BSE-infected ani-
mals (at the clinical stage of the disease) were produced 
by UR INRA 1282 Nouzilly (intracerebral inoculation) in 
the framework of the European “BSE in sheep” QLKCT 
2001–01309 program (nos. 347, 359, 378, 384, 386, 388, 
397, bearing ARQ/ARQ genotype; nos. 12, 38, 331, 337, 
341, 368, and 369 had the ARR/ARR genotype). First-pas-
sage experimental ovine BSE-infected animals 7704, 7705, 
PG0637/01, PG0638/01, PG0639/01, and PG0640/01 as 
well as second-passage animals 1630M, 1631M, 1636M, 
1637M, 1638M, 1639M, 1641M, 1643M, 1644M, and 
1645M were from VLA. Experimental caprine BSE sam-
ples were from the Institute for Animal Health, Edinburgh, 
Scotland. Nor98 isolates were from the National Veterinary 
Institute, Oslo, Norway.
Field Isolates
This study tested, in blind conditions, 270 samples 
provided by AFSSA. This represents all the TSE-positive 
cases recorded during 2002–2003 by active surveillance 
(>160,000 brain samples originating from slaughterhouse 
and rendering plants screened by rapid tests) and is thus 
representative of the diversity of French isolates. The 270 
samples included 21 caprine isolates and 42 cases of atypi-
cal scrapie previously identiﬁ  ed by AFSSA.
Homogenization of Nervous Tissues
Nervous tissues were homogenized and calibrated ac-
cording to the Bio-Rad puriﬁ  cation protocol. Homogenates 
(20% w/v) were diluted 10-fold in a negative sheep brain 
homogenate or tested undiluted if absorbance measurement 
in A reagent was <0.5.
Processing of Samples (Scrapie-associated 
Fibrils Preparation)
Two batches (A and A′ series) of 21 samples (250 μL 
(20% homogenate) of each sample per tube, manual pro-
cedure) or 29 samples (250 μL of each sample per well 
in 2 deep-well plates, automated protocol) were analyzed 
together with 2 scrapie controls (nerve tissue from 2 scrapie 
sheep, 99–1316 and PG1259 [manual] or 99–1316 and 
99–1487 [automated]) and an experimental BSE-infected 
sheep (397BS, AFSSA). Each batch was treated in 1 set of 
conditions of PK treatment. For the manual protocol, 250 
μL of A reagent (TeSeE puriﬁ  cation kit) containing PK (10 
μg) is distributed in each tube of the A series, and 250 μL of 
A′ reagent/PK (5% N-lauroylsarcosine sodium salt [w/v], 
5% [w/v] sodium dodecyl sulfate [SDS] containing 27.5 μg 
of PK) in each tube of the A′ series. All the tubes were then 
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homogenized by 10 inversions and incubated at 37°C for 
15 min. Then, 250 μL of B reagent (Bio-Rad puriﬁ  cation 
kit)/phenylmethylsulfonyl ﬂ  uoride (PMSF) (ﬁ  nal concen-
tration 4 mmol/L) was added, before homogenization and 
centrifugation for 5 min at 20,000 × g at 20°C.
For the automated protocol, the deep-well plates were 
successively incubated for 12 min at 37°C in the TeSeE 
NSP automated system. Each well of the ﬁ  rst plate was 
processed with 250 μL of A reagent/PK before 15 min of 
incubation at 37°C. Then 250 μL of the B reagent contain-
ing PMSF (12 mmol/L) was added and incubated 5 min at 
37°C. The deep-well plate was centrifuged for 10 min at 
2,000× g, 4°C. The second plate (A′ series) was processed 
similarly with the A′ reagent/PK.
For both protocols, supernatants were discarded and 
the tubes (or the plates) dried by inversion on absorbent 
paper for 5 min. Each pellet was denatured for 5 min at 
100°C with 25 μL of C reagent (Bio-Rad puriﬁ  cation kit). 
We then added 350 μL of R6 buffer containing 4 mmol/L 
AEBSF. For the ﬁ  eld isolates, serial dilutions (3- and 10-
fold in R6 buffer/AEBSF) were performed to ensure an op-
timal ELISA signal.
Immunometric Assay
All the reagents were provided by the Bio-Rad TeSeE 
Sheep & Goat detection kit. We distributed, in duplicate, 
100 μL of samples (undiluted, 3- and 10-fold diluted) and 
controls in microtiter plates coated with the ﬁ  rst anti-PrP an-
tibody. The plate reacted for 2 h at room temperature (RT). 
After 3 washing cycles (R2 buffer), 100 μL/well of the en-
zyme conjugate was added for 2-h reaction at RT. After 3 
washing cycles, 100 μL of substrate was added for 30 min in 
the dark at RT, before blocking the reaction with 100 μL of 
stopping solution and reading the absorbance at 450/620 nm. 
The mean ratio of the absorbances obtained in the 2 condi-
tions (A and A′) was calculated for each sample by selecting 
a range of appropriate dilutions providing absorbance mea-
surements ranging from 0.5 to 2.5 for A reagent.
Immunoblot
Pellets of puriﬁ  ed PrPres (TeSeE puriﬁ  cation kit) were 
denatured in Laemmli buffer for 5 min at 100°C. After 
SDS–12% PAGE, samples were blotted on polyvinylidene 
diﬂ  uoride membranes (Bio-Rad) and blocked with 5% bo-
vine serum albumin. PrP was detected by using horseradish 
peroxidase–labeled SHa31 antibody and chemilumines-
cence (ECL plus Western blotting detection system, Am-
ersham Biosciences, Piscataway, NJ, USA).
PK Range for Nor98 Isolates
Five Nor98 isolates as well as the 2 scrapie controls and 
the experimental ovine BSE were diluted in ovine negative 
brain homogenate (200- to 800-fold). In 6 sets of PK condi-
tions 250 μL of each sample was treated: 1 with 250 μL of 
A TeSeE reagent (TeSeE puriﬁ  cation kit) with 10 μg of PK 
and 5 different PK concentrations (10 μg, 15 μg, 20 μg, 25 
μg, and 30 μg) in 250 μL of A TeSeE Sheep & Goat reagent, 
named A'' reagent (TeSeE Sheep & Goat puriﬁ  cation kit).
Results
Principle of the Typing Test
The typing ELISA is based on the screening test for 
the postmortem diagnosis of BSE initially developed by the 
Commissariat à l’Energie Atomique (CEA) (32,33). After 
selective puriﬁ  cation of PrPres, the denatured PrPres is 
measured by using a sandwich assay in microtiter plates.
The capture antibody recognizes an amino terminal 
epitope, while the tracer antibody binds to the core of the 
protein (Figure 1, panel A). In the ﬁ  rst set of conditions, 
the PK digestion is performed in a control medium (mix-
ture of detergents and chaotropic agents) to preserve the N-
terminal epitope (Figure 1, panels A and B, PK treatment in 
A conditions). By varying the conditions of PK treatment, 
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Figure 1. Principle of the 2-site immunometric typing assay. In the 
screening conditions (Bio-Rad, Hercules, CA, USA), after mild 
proteinase K (PK) digestion, denatured PK-resistant prion protein 
(PrPres) is captured by the solid phase–immobilized antibody 
SAF34, recognizing the octarepeat region, and shown by the 
Bar224 tracer antibody, directed against the core of the protein (A). 
In the typing test, the PrPres-containing sample is treated in 2 sets 
of PK conditions (B). In the ﬁ  rst set of conditions (PK treatment 
in A reagent, Bio-Rad screening condition), the octarepeat region 
is maintained in scrapie- and bovine spongiform encephalopathy 
(BSE)–associated PrPres; in the second set of conditions (high 
PK concentration in A′ reagent), BSE- and labile strain–associated 
PrPres is more sensitive to PK digestion than the classic PrPres 
associated with scrapie strains. Calculation of the ratio in the 2 
conditions differentiates BSE and labile strains from classic scrapie 
strains. ab, antibody.Rapid Typing of Transmissible Spongiform Encephalopathy
PrPsc associated with the BSE strain appears more sensi-
tive to PK than most of the other prion strains. Conditions 
of PK treatment can thus be deﬁ  ned for selectively delet-
ing the epitope recognized by the capture antibody in BSE 
strain while preserving it in most scrapie strains (Figure 1, 
panel B, PK in A′ conditions), in agreement with previous 
reports (5,10,23,28).
The ﬁ  rst step of the Bio-Rad test (puriﬁ  cation and con-
centration of PrPres) was performed either manually or by 
using the NSP automated system and adapted for the typing 
test. Determination of the ratio between the 2 measurements 
(R = A/A′) allows differential detection of the BSE strain. 
In the current conditions, this ratio is <2 for most of the 
scrapie strains (manual or automated protocol) and close to 
6 and 10 for the automated and manual protocols, respec-
tively, with the BSE strain (Table 1). During the current 
study, we made 2 major changes with regards to the Bio-
Rad test: 1) we added PK inhibitors (PMSF and AEBSF) at 
2 stages of the puriﬁ  cation procedure for better control of 
PK digestion, and 2) we performed a series of dilutions to 
determine the optimal range of absorbance, which allowed 
a precise determination of the A/A′ ratio (ranging between 
0.5 and 2.5 absorbance unit, Figure 2, panels A and B). 
To minimize the interassay variations, the ratio obtained 
for each sample was further normalized by dividing it by 
the ratio obtained for the experimental ovine BSE control 
(Figure 2, panel C)
To evaluate this typing test, 37 brain samples from 25 
ARQ/ARQ sheep experimentally infected with BSE (ﬁ  rst 
or second passage) were compared with the brain samples 
of 3 controls. All samples analyzed in 3 independent ex-
periments provide A/A′ ratios >7 with a mean of 11 0.2 
± 1.4 (online Appendix Figure 1, panel A, available from 
www.cdc.gov/EID/content/14/4/608-appG1.htm). To fur-
ther investigate the possible inﬂ   uence of the genotype, 
we tested 7 spinal cord samples from experimental BSE 
bearing the ARR/ARR genotype, in at least 4 independent 
experiments. A/A′ ratios ranged from 5.5 to 6.9 (mean 6.0 
± 0.4) and were statistically different from the experimen-
tal ARQ/ARQ ovine BSE used as control (mean 8.8 ± 0.9, 
p<0.001 for all samples except no. 38, p<0.05) (online Ap-
pendix Figure 1, panel B).
Speciﬁ  city of Typing Test
We analyzed a large series of ﬁ  eld isolates identiﬁ  ed 
as TSE infected, by a rapid test, in the framework of the 
French active surveillance network. Of these 270 samples 
(153 in 2002 and 117 in 2003), 42 samples, which were ini-
tially identiﬁ  ed by using the TeSeE test, were categorized 
by AFSSA as atypical due to lack of conﬁ  rmation by other 
rapid tests or World Organization for Animal Health–mod-
iﬁ  ed SAF immunoblot (AFSSA, no. 2004-SA-0045) (34).
When tested with the automated typing test, 10 of the 
270 samples had PrPres levels below the detection limit, 
even undiluted (optical density <0.5 in A conditions). Each 
series of 32 samples included 3 internal controls (see Table 
l for results obtained for 20 different series of tests). Among 
the 2 scrapie controls, 1 (99–1316) was classiﬁ  ed as classi-
cal as it has a PK resistance similar to most of the ﬁ  eld iso-
lates; the second one (PG1259 or 99–1487) was classiﬁ  ed 
as intermediate because its PK resistance was intermediate 
between classic scrapie and experimental ovine BSE. The 
distribution of the normalized ratio recorded with the ﬁ  eld 
isolates is shown in Figure 3. The absorbance ratio under 
the 2 conditions of treatment was remarkably reproducible 
for the classic scrapie control (mean 1.6 ± 0.2), while larger 
variations were observed for experimental ovine BSE and 
the intermediate scrapie control (mean 6.4 ± 0.9 and 3.8 ± 
0.5, respectively). These results demonstrate that the pres-
ent test clearly discriminates classic scrapie strain from the 
2 other controls. Because of interassay variations, experi-
mental ovine BSE and intermediate scrapie may slightly 
overlap (Table 1), further justifying the use of normalized 
ratio (Figure 2, panel C, and Figure 3).
As shown in Figure 3, only 10 samples (3.8%) provid-
ed ratios compatible with experimental BSE (normalized 
ratio 0.7–1.3), and 28 provided ratios superior to experi-
mental BSE in sheep (normalized ratio >1.3–10.5, Figure 
3). Twenty-nine samples, as well as 4 of the 10 samples 
compatible with experimental BSE and 9 samples with 
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Table 1. Analysis of the reproducibility of the ELISA typing test* 
Sample (N = 20) 
Mean ratio A/Aƍ 
(normalized)  SD (normalized)  CV, %  95% CI (mean ± 2× SD) 
Manual protocol         
Classic scrapie 99-1316  1.3 (0.13)  0.2 (0.02)  15.4  0.9–1.7 (0.09–0.18) 
Intermediate scrapie PG1259  4.5 (0.46)  0.8 (0.08)  17.8  2.9–6.1 (0.30–0.63) 
Experimental ovine BSE 397BS  9.7 (1.00)  2.0 (0.21)  20.6  5.7–13.7 (0.59–1.41) 
Automated protocol         
Classic scrapie 99-1316  1.6 (0.25)  0.2 (0.03)  13.7  1.2–1.9 (0.19–0.30) 
Intermediate scrapie 99-1487  3.8 (0.59)  0.5 (0.08)  13.4  2.8–4.8 (0.44–0.75) 
Experimental ovine BSE 397BS  6.4 (1.00)  0.9 (0.14)  14.8  4.5–8.3 (0.70–1.30) 
*Three samples (classic scrapie 99-1316, intermediate scrapie PG1259 or 99-1487, and experimental ovine BSE 397BS) were analyzed in 20 different 
experiments using the manual or automated protocol (see Experimental Procedures). Normalized ratios are indicated in parentheses. SD, standard 
deviation; CV, coefficient of variation; CI, confidence interval; BSE, bovine spongiform encephalopathy. RESEARCH
low levels of PrPres, were previously identiﬁ  ed as atypi-
cal scrapie (open bars, Figure 3). Among the samples that 
yielded ratios compatible with experimental BSE in sheep, 
1 goat isolate, Ch636, was extensively studied because of 
its BSE-like proﬁ  le in 3 different Western blot techniques 
(1). As shown in Figure 3, this sample had a normalized 
A/A′ ratio close to 1, very similar to that for experimen-
tal goat BSE (Figure 4, panel A, Table 2). This result is 
conﬁ  rmed by the migration pattern of the nonglycosylated 
band (Figure 4, panel B, lane 6), which appears very simi-
lar to that of experimental BSE in sheep (Figure 4, panel B, 
lane 4) and of experimental goat BSE (lane 5), and different 
from that of French scrapie goat isolates (lanes 7 and 8).
Analysis of Nor98 Isolates
The typing test was used to analyze 18 sheep isolates 
from Norway (Table 3). Ratios were almost impossible to 
calculate because of the large decrease in signal in A' con-
ditions, as shown in Figure 5, panel A for 3 isolates. Only 
1 sample (Lavik) showed characteristics of a conventional 
scrapie isolate, providing an A/A' ratio of 0.84 (Figure 5, 
panel A), a normalized ratio of 0.11, and a Western blot pro-
ﬁ  le close to that of a French scrapie isolate (Figure 4, panel 
B, lanes 3 and 9; Figure 5, panel B, lanes 2 and 4). Other 
samples had a pattern that included a 12-kDa band (Figure 5, 
panel B) (19,22,34), characteristic of the Nor-98 strain.
After adapting the conditions of the PK treatment in 
the second set of measurements (A’ conditions), we ob-
served (see legend, Figure 6) a much lower A/A’ ratio for 
those Nor-98, which enables discrimination of highly sen-
sitive PK samples (nos. 24 and 26, online Appendix Figure 
2 [available from www.cdc.gov/EID/content/14/4/608-
appG2.htm] and Table 3) to mildly sensitive PK samples 
(nos. 8, 11, 16, and 22). 
Discussion
When this study was initiated, no case of natural BSE 
in small ruminants was recorded, and only a few experi-
mental ovine BSE samples were available, all belonging 
to the same PrP genotype (ARQ/ARQ), and mainly from a 
ﬁ  rst passage. The possible impact of the genotype, the route 
of infection, and the number of passages on the biochemi-
cal properties of PrPres associated with the BSE strain are 
poorly understood. Now, further data suggest that, at least 
during the second passage in sheep, the biochemical prop-
erties (glycoform pattern in brain) of the BSE agent are 
unchanged (35,36). In this study using our ELISA, small 
ruminant BSE samples clearly behaved differently from 
conventional scrapie samples. However, slight differences 
may exist (see ARQ/ARQ vs. ARR/ARR genotype in on-
612  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 14, No. 4, April 2008
Figure 2. Determination of the A/A’ ratio. A dilution series was assayed for each analyzed sample to determine the optimal range that would 
permit precise determination of the A/A′ ratio (absorbance ranging from 0.5 to 2.5 absorbance units in A reagent). A) A/A′ ratio is close to 
1 for PK-resistant prion protein (PrPres) associated with classic scrapie strains (manual protocol, see Experimental Procedures) and B) 
close to 10 for experimental ovine bovine spongiform encephalopathy (BSE)–associated PrPres. C) To minimize interassay variations, the 
ratio obtained for each sample is thus normalized by dividing by the ratio obtained for the ovine BSE sample.
Figure 3. A total of 260 French ﬁ  eld-positive isolates were analyzed 
with the automated ELISA typing test. Each series of 29 samples 
was analyzed together with 3 internal controls (classic scrapie, 
intermediate scrapie, experimental ovine bovine spongiform 
encephalopathy [BSE]). The ratio obtained for each sample was 
normalized by dividing by the experimental ovine BSE in the same 
series. Open bars represent the atypical scrapie cases. Natural 
goat BSE isolate (Ch636) is indicated.Rapid Typing of Transmissible Spongiform Encephalopathy
line Appendix Figure 1). We do not know whether these 
ﬁ  ndings reﬂ  ect differences in the PK sensitivity of PrPres 
associated with these genotypes or the inﬂ  uence of differ-
ent tissues.
The main difﬁ  culty encountered for the development 
of a typing test is evaluation of its speciﬁ  city and sensi-
tivity. In the current study, we unambiguously identiﬁ  ed 
all 37 experimental ovine BSE samples from 25 sheep, 
including 10 from a second passage. There are few data 
describing the molecular features of PrPres associated with 
experimental BSE in goats (37,38). In the framework of the 
French scrapie strain-typing network, 18 goats were ana-
lyzed by this ELISA, and 2 appeared compatible with ex-
perimental ovine and caprine BSE. One of them (Ch636), 
when analyzed with other molecular typing tests, appeared 
indistinguishable from experimental BSE and was later 
conﬁ  rmed as the ﬁ  rst natural case of BSE in a goat (1), 
after experimental transmission in wild-type and transgen-
ic mice. The second BSE compatible sample (TR041528) 
was later clearly identiﬁ  ed as a case of atypical scrapie as 
deﬁ  ned by its migration pattern (34). All these data sug-
gest a good sensitivity for our test, which unambiguously 
identiﬁ  ed all cases of experimental BSE in the sheep and 
goats tested, as well as the only natural case identiﬁ  ed to 
date in a goat.
Another key point during the development of this test 
was to ensure good reproducibility because this parameter 
clearly inﬂ  uences both sensitivity and speciﬁ  city. Ratios 
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Table 2. Analysis of the experimental caprine BSE samples using the manual ELISA typing test* 
Samples 
Mean A/Aƍ ratio 
(normalized)  SD (normalized)  CV, %  95% CI (mean ± 2×SD) 
Experimental BSE goat 1  8.2 (0.75)  1.0 (0.09)  12.2  6.2–10.2 (0.57–0.93) 
Experimental BSE goat 2  9.1 (0.83)  1.1 (0.10)  12.1  6.9–11.3 (0.63–1.04) 
99-1316  1.5 (0.14)  0.2 (0.02)  13.3  1.1–1.9 (0.10–0.17) 
PG1259  4.1 (0.38)  0.6 (0.06)  14.6  2.9–5.3 (0.27–0.49) 
Experimental ovine BSE 397BS  10.9 (1.00)  1.8 (0.17)  12.2  7.3–14.5 (0.67–1.33) 
*BSE, bovine spongiform encephalopathy; SD, standard deviation; CV, coefficient of variation; CI, confidence interval. 
Figure 4. Analysis of goats isolates with ELISA typing test and 
immunoblot. Two experimental bovine spongiform encephalopathy 
(BSE) samples in goats analyzed by using the manual typing ELISA 
(A) gave ratios similar to those of experimental BSE in sheep. 
Results are the mean of 3 independent experiments. Experimental 
goat BSE and BSE-like ﬁ   eld isolate Ch636 were analyzed by 
Western blot and compared with scrapie goat isolates (B). Lane 1, 
untreated negative brain homogenate. Lane 2, proteinase K (PK)–
treated negative brain homogenate. Lanes 3–9, PK-treated positive 
isolates: French scrapie isolate 99–1316 (lane 3); experimental 
ovine BSE 397 BS (lane 4); experimental BSE goat 2 (lane 5); 
French goat isolate Ch 636 (campaign 2002) (lane 6); French 
scrapie goat isolates Ch517 and Ch519 (campaign 2002) (lanes 7 
and 8, respectively); Norwegian scrapie isolate (Lavik, lane 9). MW, 
molecular weight.
Table 3. Normalized ratios obtained for the Norwegian isolates 
and controls* 
No. Name Normalized ratio  SD
Isolates
  Nor 98 1  Andoya  2.51 0.58
  Nor 98 4  Fiksdal 4.22 1.34
  Nor 98 5  Gasbakken 2.73 0.50
  Nor 98 6  Hardbakke 3.81 0.76
 Scr  7  Lavik 0.42 0.14
  Nor 98 8  Lindas 1.43 0.40
  Nor 98 9  Lom 5.30 1.37
  Nor 98 10  Narvik 10.43 3.56
  Nor 98 11  Oppdal 1.79 0.24
  Nor 98 12  Rauland 4.28 1.00
  Nor 98 13  Rennebu 4.23 0.55
  Nor 98 14  Seim 3.16 0.63
  Nor 98 16  Stranda 1.90 0.26
  Nor 98 17  Torsvastad  3.45 0.33
  Nor 98 19  Al 5.31 3.27
  Nor 98 20  Arnes 3.99 0.85
  Nor 98 21  Aseral 3.20 0.67
  Nor 98 22  Egersund 1.68 0.52
  Nor 98 24  Soknedal2 14.22 6.21
  Nor 98 26  Tennevoll 95.43 90.01
  Nor 98 27  Sortland 6.27 1.68
Controls
 Ov  99-1316  0.36 0.11
 PG-1259  0.45 0.14
 BSE  397BS  1.00 0
*SD, standard deviation; BSE, bovine spongiform encephalopathy.  RESEARCH
obtained for the classicalal scrapie control were highly re-
producible, whereas ratios measured for the experimental 
BSE in sheep and the intermediate scrapie control varied 
much more, leading to an overlap of the 95% conﬁ  dence 
interval (Table 1). To minimize interassay variations, the 
ratio obtained for each unknown sample was thus normal-
ized by taking as reference the ratio measured for the ovine 
BSE sample (Figure 2, panel C, and Figure 3) in the same 
experiment. This enabled us to deﬁ  ne the range of normal-
ized ratio compatible with BSE as the mean of experimental 
ovine BSE ± 2σ on the basis of reproducibility experiments 
recorded in Table 1. This range was experimentally deter-
mined between 0.7 and 1.3, leading to 3 categories for ﬁ  eld 
samples: conventional scrapie (ratio <0.7), compatible with 
BSE (0.7 <ratio <1.3), and atypical scrapie (ratio >1.3).
Only 10 (3.8%) of the 260 samples analyzed in the 
framework of the French epidemiologic surveillance net-
work during 2002–2003 gave a ratio compatible with BSE. 
Of the 10 BSE suspected samples, only 1 goat sample 
(Ch636) was later conﬁ  rmed as a true natural BSE case (1). 
This result indicates that the speciﬁ  city of this test is not 
that good because 9 false-positive results were recorded in 
260 samples (speciﬁ  city 96.5%). However, the test appears 
useful since it excluded the presence of BSE for most ﬁ  eld 
samples, thus restricting the use of more speciﬁ  c but time-
consuming methods, like experimental transmission in 
mice, to a small number of isolates. Moreover, in a single 
screening, this test classiﬁ  ed all TSE-infected isolates as a 
function of their PK resistance and thus provided a rapid 
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Figure 5. Analysis of different ovine strains by ELISA typing test and 
immunoblot. A) ELISA typing test. Three Nor98 isolates (Fiksdal, 
Stranda, and Seim) were analyzed by using the ELISA typing 
test. Absorbances obtained in the classic A′ typing reagent are 
close to 0, preventing calculation of the A/A′ ratio. Ratios obtained 
for a Norwegian scrapie isolate (Lavik) and for the 3 internal 
controls (classic Scr 99–1316, intermediate scrapie PG1259, and 
experimental ovine bovine spongiform encephalopathy [BSE] 397 
BS) are indicated. B) Pattern of migration of different ovine strains. 
Lanes 1 and 9, untreated negative brain homogenate. Lanes 2–8, 
proteinase K–treated brain homogenates: French scrapie isolate 
99–1316 (lane 2); experimental ovine BSE 397 BS (lanes 3 and 
8); Norwegian scrapie isolate (Lavik) (lane 4); Nor98 Stranda and 
Nor98 Seim scrapie isolates (lanes 5 and 6, respectively); negative 
brain homogenate (lane 7). MW, molecular weight.
Figure 6. Proteinase K (PK) sensitivity of Nor98 isolates in 
stringent and mild detergent conditions. The ELISA typing test was 
performed on Nor98 isolates, with 5 concentrations (0.4–1.1 μg per 
mg of tissue) in the stringent A′ reagent (A) or in the mild A′′ reagent, 
adapted for PK-sensitive strains (B) (see Experimental Procedures). 
A/A′ (or A/A′′) ratios were calculated for each PK concentration, 
and normalized by dividing by the A/A' ratio (or A/A′′) obtained for 
the experimental ovine bovine spongiform encephalopathy (BSE) 
sample at the maximal PK concentration. In the A’ reagent, even at 
the lowest PK concentration (PK 0.4 μg/mg tissue), the normalized 
ratios (using the experimental ovine BSE A/A′ PK1.1 ratio) obtained 
for the Nor98 isolates are >1, thus being 3× more sensitive than 
experimental ovine BSE. To evaluate possible differences in PK 
sensitivity among Nor98 isolates, this experiment was reproduced 
with the A′′ reagent (panel B), which is 3- to 6-fold more protective 
than the A′ reagent, as shown by the corresponding normalized 
ratios (A′ or A′′ reagent) for the same PK concentration (1.1 μg PK/
mg of tissue).Rapid Typing of Transmissible Spongiform Encephalopathy
classiﬁ  cation of sheep isolates according to this criterion. 
The test could also be modiﬁ  ed, by adjusting the range of 
PK sensitivity, to classify Nor-98 isolates.
All these data demonstrate that this ELISA-based typ-
ing test is suitable for a routine analysis of ﬁ  eld samples, 
as assessed by the positive evaluation from the European 
Commission as one of the tests recommended to identify the 
possible presence of BSE in small ruminant ﬂ  ocks (http://
eur-lex.europa.eu/LexUriServ/site/en/oj/2005/l_010/
l_01020050113en00090017.pdf). These typing tests are 
mainly designed to identify the BSE strain in small rumi-
nant ﬂ  ocks. They are performed exclusively in national ref-
erence laboratories and based on Western blot techniques. 
In this context, the present ELISA is one of the secondary 
tests to be used to conﬁ  rm BSE suspicion. We believe it 
will help clarify the status of these unusual isolates.
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